首页 正文

Geniposide reverses oxaliplatin resistance in colorectal cancer via suppression of PI3K/AKT pathway

{{output}}
Background: As a first-line chemotherapy agent for colorectal cancer (CRC), oxaliplatin suffers from limited efficacy due to acquired resistance. This study investigated whether geniposide can overcome oxaliplatin resistance in p... ...